Brachytelephalangic chondrodysplasia punctata
Learn about Brachytelephalangic chondrodysplasia punctata, its reported features, relevant specialists, and questions to discuss at a medical consultation.
The sources compiled here do not cover: diagnosis, treatment, prevention, prognosis. Ask the treating doctor about these.
What it is
From: Orphanet
Brachytelephalangic chondrodysplasia punctata (BCDP) is a form of non-rhizomelic chondrodysplasia punctata, a primary bone dysplasia, characterized by hypoplasia of the distal phalanges of the fingers, nasal hypoplasia, epiphyseal stippling appearing in the first year of life, as well as mild and non-rhizomelic shortness of the long bones.
Reported clinical features and what the terms mean
The following findings are associated with this condition in Orphanet. They are not a checklist for diagnosing yourself, and they do not all occur in every affected person. Some are examination, imaging or laboratory findings that cannot be recognised at home.
The frequency labels describe how often a finding was reported among people with the condition in the source. They do not give the chance that a person with that symptom has the condition. Definitions below reproduce HPO terminology; they explain the term, not the likely severity in an individual.
- Abnormal enzyme/coenzyme activity · Very frequent (99-80%)
- Concentration or activity of an enzyme is above or below the limits of normal in the blood circulation.
- Hypoplasia of the maxilla · Very frequent (99-80%)
- Abnormally small dimension of the Maxilla. Usually creating a malocclusion or malalignment between the upper and lower teeth or resulting in a deficient amount of projection of the base of the nose and lower midface region.
- Short distal phalanx of finger · Very frequent (99-80%)
- Short distance from the end of the finger to the most distal interphalangeal crease or the distal interphalangeal joint flexion point. That is, hypoplasia of one or more of the distal phalanx of finger.
- Short nose · Very frequent (99-80%)
- Distance from nasion to subnasale more than two standard deviations below the mean, or alternatively, an apparently decreased length from the nasal root to the nasal tip.
- Abnormality of the vertebral column · Frequent (79-30%)
- Any abnormality of the vertebral column.
- Broad nasal tip · Frequent (79-30%)
- Increase in width of the nasal tip.
- Depressed nasal ridge · Frequent (79-30%)
- Lack of prominence of the nose resulting from a posteriorly-placed nasal ridge.
- Epiphyseal stippling · Frequent (79-30%)
- The presence of abnormal punctate (speckled, dot-like) calcifications in one or more epiphyses.
- Hypoplasia of the anterior nasal spine · Frequent (79-30%)
- Underdevelopment of the anterior nasal spine of maxilla.
- Mixed hearing impairment · Frequent (79-30%)
- A type of hearing loss resulting from a combination of conductive hearing impairment and sensorineural hearing impairment.
- Postnatal growth retardation · Frequent (79-30%)
- Slow or limited growth after birth.
- Proportionate short stature · Frequent (79-30%)
- A kind of short stature in which different regions of the body are shortened to a comparable extent.
- Punctate vertebral calcifications · Frequent (79-30%)
- The presence of punctiform calcification of the bone of the vertebral bodies.
- Short columella · Frequent (79-30%)
- Reduced distance from the anterior border of the naris to the subnasale.
Other findings in the same source
From: Orphanet
Additional reported features include Short distal phalanx of toe (Frequent (79-30%)); Abnormal bronchus morphology (Occasional (29-5%)); Abnormality of hyoid bone (Occasional (29-5%)); Abnormality of the costochondral junction (Occasional (29-5%)); Asthma (Occasional (29-5%)); Atlantoaxial instability (Occasional (29-5%)); Butterfly vertebrae (Occasional (29-5%)); C1-C2 subluxation (Occasional (29-5%)); Calcaneal epiphyseal stippling (Occasional (29-5%)); Central apnea (Occasional (29-5%)). This is a selected summary, not a complete description of the condition.
When it may begin
From: Orphanet
Antenatal; Neonatal
Inheritance in the source
From: Orphanet
X-linked recessive
Frequency and the population described
From: Orphanet
Point prevalence: Unknown; Worldwide; Class only.
Understanding the inheritance label
From: MedlinePlus Genetics
An X-linked recessive pattern involves a gene on the X chromosome. The number of X chromosomes and the particular genetic change influence how a condition is expressed. A genetic counsellor should interpret the result and the family history before discussing risks for relatives or future pregnancies.
Which doctor should you see?
The suggested department for discussing Brachytelephalangic chondrodysplasia punctata is Orthopaedics, with a orthopaedic specialist as the relevant type of clinician. General physician / Family Medicine; paediatrician for children. Referral depends on symptoms.
Additional services that may be relevant, depending on the findings, include: Clinical Genetics.
This is an editorial referral starting point. The appropriate clinic depends on the person’s age, symptoms, previous diagnosis and local services. The first clinician can decide whether another specialty or a team is needed; a department label does not confirm the diagnosis.
How to prepare for an assessment
Bring a short timeline of the main symptoms: when they first appeared, whether they are constant or episodic, what seems to change them, and how they affect daily activities. Include previous reports, discharge summaries, current medicines and supplements, allergies, and any relevant family history. A dated record is more useful than trying to match every feature in an online article.
Ask the clinician what is already established and what remains uncertain. If a test is suggested, ask what question it answers, what its limitations are and how the result would change the next step. The information here is not an instruction to arrange every possible test. In children, bring growth, developmental and school information if it is relevant to the concern.
- What explains the change in pain, movement or function?
- Which activities need adjustment while the diagnosis is being clarified?
- What are the roles of rehabilitation, observation and surgery in this situation?
Treatment discussions and follow-up
The material gathered for this draft does not provide a complete condition-specific treatment pathway for Brachytelephalangic chondrodysplasia punctata. That gap does not mean that treatment is unavailable. A clinician needs to establish the diagnosis and review current guidance before recommending medicines, procedures, rehabilitation or other support.
Before leaving the appointment, clarify the next review date, who will communicate results, and whom to contact if the situation changes. Discuss difficulties with sleep, work, school, mobility, eating or emotional wellbeing when these are relevant. Practical support may require coordination between the treating clinician and other services.
The collected references do not establish a complete prevention or long-term outlook section for this entry. Missing information should not be interpreted as proof that prevention is impossible or that a particular outcome is inevitable. Ask what is known for the exact subtype, stage and personal circumstances, and which uncertainties remain.
When to seek emergency help
Severe breathing difficulty, collapse, new stroke-like symptoms, a seizure that is prolonged or repeated without recovery, uncontrolled major bleeding, or an immediate risk of self-harm require emergency help. In India, call 112 or reach the nearest emergency department. This is a general, non-exhaustive warning list; it is not a condition-specific triage tool.
This condition is usually assessed by an orthopaedic surgeon. Every profile shows the doctor’s registration and what has been checked.
Sources
- Orphanet — Brachytelephalangic chondrodysplasia punctata — Orphadata Science, CC BY 4.0
- Human Phenotype Ontology Consortium — terminology definitions — HPO licence; definitions reproduced without alteration
- MedlinePlus Genetics — inheritance patterns — Public-domain Genetics education
- Government of India — Emergency Response Support System — Official reference for India emergency number
Source: MedlinePlus, National Library of Medicine. Orphadata Science: Free access data from Orphanet. © INSERM 1999; July 2026 data, CC BY 4.0. This product uses the Human Phenotype Ontology (hp/releases/2026-09-01). Only sources listed for this article apply. Source material has been selected and arranged; HPO definitions are reproduced without alteration. No source organisation endorses this compilation. Köhler S et al. The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data. Nucleic Acids Research 2014;42(D1):D966–D974. doi:10.1093/nar/gkt1026.
General information, not advice about your situation. Errors can be reported through the corrections process. Reference TDI-C-0385.